Kubiak Katarzyna, Malinowska Katarzyna, Langer Ewa, Dziki Łukasz, Dziki Adam, Majsterek Ireneusz
Department of Chemistry and Clinical Biochemistry, Medical University in Łódź.
Pol Przegl Chir. 2011 Mar;83(3):155-60. doi: 10.2478/v10035-011-0024-6.
Colorectal cancer (CRC) is a serious medical and economical problem of our times. It is the most common gastrointestinal cancer in the world. In Poland, the treatment and detection of CRC are poorly developed and the pathogenesis is still unclear. One hypothesis suggests a role of reactive oxygen species (ROS) in the pathogenesis of CRC. Experimental studies in recent years confirm the participation of ROS in the initiation and promotion of CRC. The aim of the study was to examine the effect of the following coordination compounds coordination compounds: dinitrate (V) tetra(3,4,5-trimethyl-N1-pyrazole-κN2) copper(II), dichloro di(3,4,5-trimethyl-N1-pyrazole-κN2) copper(II), dinitrate (V) di(1,4,5-trimethyl-N1-pyrazole-κN2) copper(II), dichloro di(1,3,4,5-tetramethyl-N1-pyrazole-κN2) copper(II) on the activity of antioxidant enzymes superoxide dismutase (SOD, ZnCu-SOD) and catalase (CAT) in a group of patients with colorectal cancer (CRC) and in the control group consisting of patients with minor gastrointestinal complaints.
The study was conducted in 20 patients diagnosed with colorectal cancer at the age of 66.5±10.2 years (10 men and 10 women) versus the control group of 20 people (10 men and 10 women) aged 57.89±17.10 years without cancer lesions in the biological material - hemolysate prepared in a proportion of 1ml of water per 1 ml of blood. CAT activity was measured by the Beers method (1952), while SOD activity was measured by the Misra and Fridovich method (1972).
We found that patients with CRC showed a statistically significant decrease of SOD and CAT activity (CAT - 12,75±1.97 U/g Hb, SOD - 1111.52±155.52 U/g Hb) in comparison with the control group (CAT - 19.65±2,17 U/g Hb, SOD - 2046.26±507.22 U/g Hb). Simultaneously, we observed that the investigated coordination compounds of Cu(II) significantly increased the antioxidant activity of CAT and SOD in patients with CRC (mean: CAT 25.23±4.86 U/g Hb, SOD - 3075.96±940.20 U/g Hb).
Patients with colorectal cancer are characterized by reduced activity of antioxidant enzymes catalase and superoxide dismutase which suggests impaired antioxidant barrier. Therefore, coordination compounds of Cu (II), which enhance the activity of CAT and SOD, may prove useful in the prevention and treatment of colorectal cancer.
结直肠癌(CRC)是我们这个时代严重的医学和经济问题。它是世界上最常见的胃肠道癌症。在波兰,CRC的治疗和检测发展不佳,其发病机制仍不清楚。一种假说认为活性氧(ROS)在CRC发病机制中起作用。近年来的实验研究证实了ROS参与CRC的发生和发展。本研究的目的是研究以下配位化合物:二硝酸(V)四(3,4,5-三甲基-N1-吡唑-κN2)铜(II)、二氯二(3,4,5-三甲基-N1-吡唑-κN2)铜(II)、二硝酸(V)二(1,4,5-三甲基-N1-吡唑-κN2)铜(II)、二氯二(1,3,4,5-四甲基-N1-吡唑-κN2)铜(II)对一组结直肠癌(CRC)患者和由胃肠道轻微不适患者组成的对照组中抗氧化酶超氧化物歧化酶(SOD,锌铜超氧化物歧化酶)和过氧化氢酶(CAT)活性的影响。
本研究对20例年龄为66.5±10.2岁的结直肠癌患者(10名男性和10名女性)与20名年龄为57.89±17.10岁的对照组患者(10名男性和10名女性)进行,对照组患者生物材料(以每1ml血液加1ml水的比例制备的溶血产物)中无癌症病变。CAT活性采用Beers法(1952年)测定,而SOD活性采用Misra和Fridovich法(1972年)测定。
我们发现,与对照组(CAT - 19.65±2.17 U/g Hb,SOD - 2046.26±507.22 U/g Hb)相比,CRC患者的SOD和CAT活性在统计学上显著降低(CAT - 12.75±1.97 U/g Hb,SOD - 1111.52±155.52 U/g Hb)。同时我们观察到,所研究的铜(II)配位化合物显著提高了CRC患者CAT和SOD的抗氧化活性(平均值:CAT 25.23±4.86 U/g Hb,SOD - 3075.96±940.20 U/g Hb)。
结直肠癌患者的特征是抗氧化酶过氧化氢酶和超氧化物歧化酶活性降低,这表明抗氧化屏障受损。因此,能增强CAT和SOD活性的铜(II)配位化合物可能在结直肠癌的预防和治疗中有用。